Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

model of DNA double helix
August 20, 2015

New type of trial shows promise for several cancers

Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation.

By VUMC News and Communications
August 20, 2015

Rathmell to lead new Center for Immunobiology

Jeffrey Rathmell, Ph.D., has been recruited to Vanderbilt University Medical Center (VUMC) to lead a new Center for Immunobiology, a structure supported by the Department of Pathology, Microbiology and Immunology, the Department of Medicine and Vanderbilt-Ingram Cancer Center (VICC).

By VUMC News and Communications
concept illustration of knee with pain radiating from it
August 6, 2015

New targeted therapy shows promise for rare joint tumor

Vanderbilt-Ingram Cancer Center (VICC) investigators and colleagues at several major medical centers have been testing a new targeted therapy that is showing promise for the treatment of a rare tumor that forms in and around joint cavities.

By VUMC News and Communications
July 30, 2015

Brown to head cancer registry for Y-90 tumor treatments

Dan Brown, M.D., professor of Radiology and Radiological Sciences and chief of Interventional Oncology, will spearhead a national Vanderbilt-led research registry that tracks cancer patients whose tumors are treated with Yttrium-90 (Y-90), a radioactive isotope.

By VUMC News and Communications
July 30, 2015

Singer’s selfless gift benefits lung cancer program

In a town full of amazing singers, Nashville songstress Dawn Sears’ voice was something special.

By VUMC News and Communications
July 23, 2015

Damon Runyon cancer grant boosts Davila’s research

Marco Davila, M.D., Ph.D., assistant professor of Medicine and of Cancer Biology, has received a grant from the Damon Runyon Cancer Research Foundation that will provide $450,000 over three years to help fund his research on therapies for several types of blood disorders, including various forms of leukemia and non-Hodgkin (also known as non-Hodgkin’s) lymphoma.

By VUMC News and Communications
July 9, 2015

Arteaga, AACR push for cancer research funding

Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), recently joined other cancer research leaders in a meeting with members of Congress to discuss precision medicine in cancer and the need for continued federal support for cancer research.
By VUMC News and Communications
June 25, 2015

Award-winning VICC investigators in spotlight at ASCO

The 2015 Annual Meeting of the American Society of Clinical Oncology, held May 29 - June 2 in Chicago, put multiple Vanderbilt-Ingram Cancer Center investigators in the spotlight.
By VUMC News and Communications
June 18, 2015

Vanderbilt earns acclaim for employee health initiatives

Vanderbilt University Medical Center has again been recognized for a strong and enduring commitment to helping employees and their families live healthy lives.
By VUMC News and Communications
June 11, 2015

Lung cancer foundation lauds Massion’s contributions

Pierre Massion, M.D., director of the Thoracic Program and an Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has been recognized for his pioneering work in lung cancer by the LUNGevity Foundation.
By VUMC News and Communications
May 28, 2015

Dietitian and friends donate chemo care bags to VICC patients

A Nashville-based dietitian who lost her mother to cancer is using the power of social media to raise funds for chemo care bags for cancer patients.
By VUMC News and Communications
May 28, 2015

Hackett lauded as one of Women to Watch in health care

Lauren Hackett, MPA, executive director of Administration at Vanderbilt-Ingram Cancer Center (VICC) and chief business officer for Oncology, Imaging and Quantitative Sciences Administration, has been chosen as one of the 2015 Women to Watch by Nashville Medical News.
By VUMC News and Communications
May 21, 2015

VICC Annual Retreat focuses on immunotherapy

Efforts to enable the immune system to “see” the cancer and attack the aberrant cells were the prime focus during Vanderbilt-Ingram Cancer Center’s Annual Retreat, held April 30 at the Vanderbilt University Student Life Center.
By VUMC News and Communications
1 … 37 38 39 40 41 … 55